In defiance of FTC and EU scrutiny, Illumina Inc (NASDAQ: ILMN) went ahead to complete its billion acquisition of Grail. The finalization of the buyout comes as the FTC sued to block the move in March ...
SAN DIEGO--(BUSINESS WIRE)--Illumina, Inc. (NASDAQ: ILMN) today affirmed its commitment to re-acquire GRAIL, a healthcare company focused on multi-cancer early detection. “This acquisition is ...
The General Court of the European Union ruled Wednesday that the European Commission can proceed with its review of the Illumina (NASDAQ:ILMN) acquisition of Grail. Illumina lost its challenge in ...
Robust net income recovery in Q3 2024, showcasing a significant turnaround from the previous year's loss. Consistent growth in sequencing consumables revenue, highlighting a strong demand for Illumina ...
The Chinese government took its economic sanctions against San Diego-based Illumina a step further Tuesday by banning the gene-sequencing company from importing its machines to the country. It’s part ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback